Harpreet is the President and founder of EVR Consulting, established in 2011. Harpreet’s pursuits have fervently been directed towards the advancement and execution of programs aimed at facilitating access to vital rare disease medications in low-to-middle-income countries (LMICs). As a visionary initiator, Harpreet spearheaded the inception of the Global Alliance for Rare Disease Access (GARDaccess) project. This initiative underscores her commitment to fostering collaboration among diverse stakeholders, with the ultimate objective of establishing sustainable pathways to rare disease medications for those in need.